“Life has not become simpler and easier. It’s become more complex. Success requires acknowledging this complexity early and building flexibility into every aspect of the business model.” Renée Aguiar-Lucander is the CEO of Hansa Biopharma, appointed in April 2025. Renée
“The differentiator in our business isn’t the equipment and the facility—it’s the scientists working with customers to create assays and solve complex scientific challenges.” Leon Wyszkowski has spent nearly three decades in drug development, including 20 years at Thermo Fisher
“Poland is no longer an emerging market. It’s a partnering market.” Dr. Magdalena Kulczycka, founder of the Biotech Innovation Institute, is a molecular biologist with experience spanning academia, entrepreneurship, and venture capital. Her institute fosters biotech growth from lab to
“We invest emotionally and intellectually in their journey—when their product reaches patients, that’s our success too.” Janet Hoogstraate, CEO of NorthX Biologics, brings ~30 years of pharmaceutical experience spanning from preclinical development to GMP production for marketed products, with leadership
“There are 437 active clinical trials in radiopharmaceuticals, and 100 companies developing them. If your logistics are not better, there is no other differentiator. You need to compete by experience.” When Kostja Paschalidis and his co-founder left their roles developing
Chris Kilbee is Co-Founder of Life Science Networks Can you tell us a little about your background and how you came to join our company? Prior to launching Life Science Networks, my 25-year career has been spent firstly in B2B
Help us find the most innovative and trusted suppliers in Pharma and Biotech.
